Why Nabriva Therapeutics Stock Is Falling Today [The Motley Fool]
Paratek Pharmaceuticals, Inc. (PRTK)
Last paratek pharmaceuticals, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.paratekpharma.com
Company Research
Source: The Motley Fool
Shares dropped after the biotech reported what seemed like good news. What's going on? Brian Feroldi ( TMFTypeoh ) May 21, 2018 at 11:59AM What happened After the company announced top-line data from an important phase 3 trial, shares of Nabriva Therapeutics ( NASDAQ:NBRV ) , a clinical-stage biotech focused on next-generation antibiotics , fell as much as 14% in morning trading on Monday. As of 11:20 a.m. EDT, the stock was down 9%. So what Nabriva announced top-line results from its Leap 2 study today. This phase 3 trial is designed to test lead compound lefamulin as a treatment for community-acquired bacterial pneumonia (CABP) compared to the current standard-of-care treatment moxifloxacin. Here are the key takeaways from the trial: Lefamulin achieved all of the Food and Drug Administration's and the European Medicines Agency's prim
Show less
Read more
Impact Snapshot
Event Time:
PRTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTK alerts
High impacting Paratek Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics